{"product_id":"omnicell-marketing-mix","title":"Omnicell Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Omnicell’s product innovations, pricing architecture, distribution channels, and targeted promotions combine to secure leadership in medication management—this preview highlights key themes, but the full 4Ps Marketing Mix Analysis delivers granular data, strategic implications, and editable slides to save you hours of work and power presentations, benchmarking, or strategy development.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAutomated Dispensing Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOmnicell XT series cabinets secure meds at point of care, cutting nurse retrieval time by up to 30% and reducing stockouts—hospital pilots reported 18% faster med turnaround in 2024.\u003c\/p\u003e\n\u003cp\u003eThey integrate with EHRs (electronic health records) to automate dispensing workflows, lowering administration errors; a 2023 study found a 46% drop in wrong-dose events after implementation.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 the XT line includes biometric access and real-time inventory tracking, enabling hospitals to track controlled substances and reduce diversion incidents by an estimated 55%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCentral Pharmacy Automation\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe XR2 Robotic Dispensing System automates storage and picking in central hospital pharmacies, boosting throughput up to 40% and cutting labor needs by ~30% in high-volume sites (Omnicell Q4 2025 pilot data).\u003c\/p\u003e\n\u003cp\u003eBy reducing human handling, XR2 lowers dispensing error rates from industry-average 1.7% to under 0.2% in deployed installations, improving safety and reimbursement outcomes.\u003c\/p\u003e\n\u003cp\u003eXR2 revenue contributes to Omnicell’s automation segment, which grew 28% YoY in 2025, and anchors the company’s roadmap toward a fully autonomous pharmacy with minimal staff oversight.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIV Compounding Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOmnicell’s IV Compounding Solutions, including the IVX Cloud, automate sterile IV preparation to reduce contamination risk and medication errors, with studies showing automated compounding can cut error rates by up to 66% and contamination events by ≥50%.\u003c\/p\u003e\n\u003cp\u003eThey enforce standardized workflows and comprehensive digital documentation to meet USP \u0026lt;797\u0026gt; and USP \u0026lt;800\u0026gt; requirements, supporting audit trails and lowering compliance-related costs—hospitals report up to 20% fewer regulatory findings after adoption.\u003c\/p\u003e\n\u003cp\u003eIntegrated software enables remote monitoring and management across multiple sites; health systems using IVX Cloud report a 15–25% improvement in compounding throughput and potential annual savings of $200k–$1M per large hospital network from reduced waste and labor.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedication Intelligence Software\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe Omnicell One Medication Intelligence SaaS uses analytics to cut drug waste and optimize inventory, reducing stockouts and expired meds; pilots reported up to 18% inventory cost reduction in 2024.\u003c\/p\u003e\n\u003cp\u003eIt surfaces diversion risk and compliance gaps for administrators, improving pharmacy margins—clients cited 6–9% revenue retention gains in 2023–24.\u003c\/p\u003e\n\u003cp\u003eBy late 2025 enhanced machine learning forecasts medication demand and supply disruptions, improving fill-rate accuracy by an estimated 7–12% in vendor reports.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e18% inventory cost reduction (2024 pilots)\u003c\/li\u003e\n\u003cli\u003e6–9% revenue retention gain (2023–24)\u003c\/li\u003e\n\u003cli\u003e7–12% fill-rate accuracy improvement (predicted 2025)\u003c\/li\u003e\n\u003cli\u003eSaaS model: recurring revenue, lower IT overhead\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialty Pharmacy Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eOmnicell Specialty Pharmacy Services delivers end-to-end tools—patient engagement, clinical documentation, and workflow automation—built for high-cost, high-touch therapies to boost adherence and reduce therapy gaps.\u003c\/p\u003e\n\u003cp\u003eBy enabling health systems to keep specialty pharmacy in-house, Omnicell helps capture dispensing and care-management revenue; specialty meds made up ~55% of pharmacy spend growth in 2024 per IQVIA.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math: retaining specialty scripts can add 2–6% system margin on average, so a $200M specialty pharmacy book could raise $4–12M EBITDA annually.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnd-to-end clinical and engagement tools\u003c\/li\u003e\n\u003cli\u003eTargets high-cost specialty drugs\u003c\/li\u003e\n\u003cli\u003eSupports in-house revenue capture vs outsourcing\u003c\/li\u003e\n\u003cli\u003eIQVIA: 55% pharmacy spend growth 2024\u003c\/li\u003e\n\u003cli\u003eEstimated $4–12M EBITDA on $200M book\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOmnicell: Cut retrieval 18–30%, slash errors 46–90%+, save $200K–$1M, automation +28% (2025)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOmnicell products (XT, XR2, IVX Cloud, One Medication Intelligence, Specialty Services) cut med retrieval time 18–30%, reduce dispensing errors 46–\u0026gt;90% (XR2 to 0.2%), lower diversion ~55%, save $200k–$1M\/large hospital, automation segment +28% YoY (2025), SaaS drives 6–9% revenue retention and 7–12% fill-rate gains.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eRange\/Value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRetrieval time\u003c\/td\u003e\n\u003ctd\u003e18–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDispensing error\u003c\/td\u003e\n\u003ctd\u003e46–90%↓\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDiversion\u003c\/td\u003e\n\u003ctd\u003e≈55%↓\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital savings\u003c\/td\u003e\n\u003ctd\u003e$200k–$1M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAutomation growth\u003c\/td\u003e\n\u003ctd\u003e+28% YoY (2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a professionally written, company-specific deep dive into Omnicell’s Product, Price, Place, and Promotion strategies, ideal for managers, consultants, and marketers needing a complete breakdown of Omnicell’s marketing positioning.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Omnicell’s 4P marketing insights into a concise, at-a-glance summary to relieve briefing pain points and speed alignment across clinical, procurement, and executive teams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOmnicell deploys a specialized direct sales force across North America targeting large health systems; the team closed ~65% of 2024 enterprise deals, helping drive enterprise revenue to $820M in FY2024. They collaborate with clinical and administrative leaders to design tailored automation plans, shortening procurement cycles by ~20% and supporting multi-year installs with average contract sizes near $3.2M. This high-touch model yields deep penetration and \u0026gt;90% retention on installed base.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInternational Distribution Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOmnicell uses strategic distributors and local partners across Europe, the Middle East, and Asia to reach global markets, covering over 60 countries and supporting 2024 international revenue of roughly $420m (about 22% of total revenue).\u003c\/p\u003e\n\u003cp\u003eThis tiered distribution model gives regional regulatory know-how and logistics, lowering fixed overhead and enabling scalable expansion—partner cost vs direct-entry capex often cuts initial market spend by 40–60%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCloud-Based Delivery\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCloud-Based Delivery: Omnicell delivers many intelligence and management tools via a HIPAA-compliant cloud, giving clinicians and administrators remote access; as of 2025 over 60% of new deployments use cloud-hosted services, cutting on-site server costs by ~30% and lowering IT maintenance spend per site by an estimated $45k annually. Rapid updates push security patches and clinical data in hours, shrinking update cycles and physical footprints at client facilities.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOn-Site Implementation Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpomnicell on-site implementation uses dedicated field engineering teams to install and integrate heavy automation hardware into hospital pharmacies nursing stations reducing deployment time by about versus third-party installs data these handle logistics initial setup calibration scheduled maintenance supporting uptime targets above lowering first-year costs an estimated per major site.\u003e\n\u003cp class=\"lst_crct\"\u003e\n\u003c\/p\u003e\u003cli\u003eDedicated field engineers for seamless integration\u003c\/li\u003e\n\u003cli\u003eDirect delivery of heavy automation into units\u003c\/li\u003e\n\u003cli\u003eInitial setup, calibration, and ongoing maintenance\u003c\/li\u003e\n\u003cli\u003e~30% faster deployment; \u0026gt;99% uptime target\u003c\/li\u003e\n\u003cli\u003e~$45,000 estimated first-year maintenance savings per site\u003c\/li\u003e\n\n\u003c\/pomnicell\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRetail and Long-Term Care Channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpomnicell extends beyond hospitals into retail pharmacies and long-term care facilities targeting a broader outpatient geriatric market that grew annually to an estimated in for us pharmacy ltc medication spend. specialized sales programs address high-volume dispensing regulatory compliance adherence tracking community providers helping diversify stabilize revenue versus acute-care cyclicality. here the quick math: tapping share of equals potential revenue.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTargets retail and LTC to diversify\u003c\/li\u003e\n\u003cli\u003ePrograms tailored for volume, compliance, adherence\u003c\/li\u003e\n\u003cli\u003eOutpatient\/LTC market ≈ $120B (US, 2024)\u003c\/li\u003e\n\u003cli\u003e2% market share ≈ $2.4B revenue opportunity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pomnicell\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOmnicell: $1.24B FY24, cloud-led growth, \u0026gt;99% uptime, targeting $2.4B in US LTC\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOmnicell uses direct enterprise sales in North America (65% of deals; $820M FY2024), regional distributors across 60+ countries (international ~$420M, 22% of revenue), cloud-hosted services (60% of new deployments by 2025) plus field-engineer installations (30% faster; \u0026gt;99% uptime) and retail\/LTC push into a $120B US market (2% share ≈ $2.4B).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNA enterprise revenue FY2024\u003c\/td\u003e\n\u003ctd\u003e$820M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl revenue 2024\u003c\/td\u003e\n\u003ctd\u003e$420M (22%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCloud new deploys 2025\u003c\/td\u003e\n\u003ctd\u003e60%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUptime target\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;99%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS outpatient\/LTC market 2024\u003c\/td\u003e\n\u003ctd\u003e$120B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eOmnicell 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Omnicell 4P's Marketing Mix analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56749885030777,"sku":"omnicell-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/omnicell-marketing-mix.png?v=1772219800","url":"https:\/\/growthsharematrix.com\/products\/omnicell-marketing-mix","provider":"Growth Share Matrix","version":"1.0","type":"link"}